Healthcare Professionals Investor Login Turkish
About Trustlife Labs Drug R&D Center News Contact
Trustlife

Scientific Documents

Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis

Breast CancerInnovative Drug DevelopmentPanel

19.12.2023

Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis

Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis

Nadjiba ZEGHEBa,b *, Aicha ADAIKAa , Touhami LANEZa , Tuba Tüylü Küçükkılınç

Exploring N-Ferrocenylmethylaniline Derivatives as Potent Anti-Breast Cancer Agents: Insights from Computational Chemistry, Pharmacokinetics, and QSAR Analysis from Trustlife

You may also be interested in

  • Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife
    Visits

    Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife

  • Investing in the Future of Medicine
    Recent News

    Investing in the Future of Medicine

  • Trustlife as an Innovative Health Technologies Platform: A Transformative and Collective Business Model
    Blog

    Trustlife as an Innovative Health Technologies Platform: A Transformative and Collective Business Model

Trustlife
About Trustlife Labs Drug R&D Center Contact